Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02533115
Title EAP of CPX-351 (VYXEOS) for Patients 60-75 Years of Age With Secondary AML
Acronym 401
Recruitment Approved for marketing
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Celator Pharmaceuticals
Indications
Therapies
Age Groups: senior
Covered Countries USA

Facility Status City State Zip Country Details
UCLA Ronald Reagan Medical Center Los Angeles California 90095 United States Details
Northside Hospital Atlanta Georgia 30342 United States Details
Rush University Medical Center Chicago Illinois 60612 United States Details
Franciscan St. Francis Health Indianapolis Indiana 46237 United States Details
The University of Kansas Hospital Kansas City Kansas 66160 United States Details
Weill Cornell Medical College- NY Presbyterian Hospital New York New York 10021 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field